Why Shares in Arcutis Biotherapeutics Surged Again This Week
Arcutis Biotherapeutics(US:ARQT) The Motley Fool·2025-11-21 08:47The company continues to receive good news from the Food and Drug Administration.Shares in Arcutis Biotherapeutics (ARQT 2.01%) continued their excellent run in 2025 (up 96%) with another 9.3% rise in the week to Friday morning. This week's move comes as the Food and Drug Administration (FDA) accepted a supplemental New Drug Application (sNDA) for Arcutis' Zoryve (roflumilast) cream. The development raises confidence that the company will be able to extract full value from Zoryve across various indications. ...